Cancer BiologybioRxivPreprint
ERBB signalling contributes to immune evasion in KRAS-driven lung adenocarcinoma
S. Laing, B. Kruspig, R. Shaw…·D. J. Murphy
The paper investigates how ERBB signaling contributes to immune evasion in KRAS-driven lung adenocarcinoma using a novel mouse model and finds that transient ERBB blockade can restore immune surveillance when combined with PD1 blockade.
DOI 10.1101/2023.07.24.550274